Product Code: ETC070067 | Publication Date: Jul 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
Indonesia is rapidly emerging as one of the largest biobanking markets in Southeast Asia. The growth of this market can be attributed to increasing research investments from public and private sectors, technological advancements that enable better management of data storage systems, and rising awareness about personalized medicine among medical practitioners. Additionally, Indonesia growing population ? now over 261 million people ? provides an abundance of biosamples for researchers exploring new treatments and cures for diseases such as cancer or diabetes.
The Indonesia government has increased its healthcare infrastructure budget from 2% in 2011 to 4-5% today with plans to further increase it up to 7%. This policy will result in better quality healthcare services which should drive the demand for biobanks throughout Indonesia as hospitals look towards purchasing newer technologies like cryopreservation chambers that are used for storing biological samples at low temperatures (-80C). In addition to expanding its healthcare infrastructure budget, the Indonesia government has also made significant investments into funding scientific research initiatives through grants. For example, funds allocated under DIPA (Directorate General Budget Financing) have been earmarked specifically for biotech projects related activities including those involving tissue collections and sample processing/analysis. This investment could potentially catalyze additional interest amongst both public sector institutions looking into setting up their own biobanks or collaborations between universities/hospitals who want access patient samples on a larger scale than what they currently have access too via individual patients seen during clinical visits. As a result, we expect more organizations looking towards establishing partnerships with reputable international players offering world-class solutions when it comes developing customized software applications tied directly into their existing laboratory information management systems (LIMS).
While there are several drivers pushing forward the development of biobanking activities within Indonesia`s borders - regulated products remain subject stringent laws set forth by various governmental entities across different levels including regional governments (Daerah), central government ministries (DepKes dan Kemenkes), local health administrations offices etc? These regulations often lag behind other countries making it difficult if not impossible sometimes for companies wanting establish themselves here even despite having superior technologies already being utilized elsewhere around globe.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Biobanking Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Biobanking Market Revenues & Volume, 2020 & 2027F |
3.3 Indonesia Biobanking Market - Industry Life Cycle |
3.4 Indonesia Biobanking Market - Porter's Five Forces |
3.5 Indonesia Biobanking Market Revenues & Volume Share, By Type, 2020 & 2027F |
3.6 Indonesia Biobanking Market Revenues & Volume Share, By Applications, 2020 & 2027F |
3.7 Indonesia Biobanking Market Revenues & Volume Share, By Sample Type, 2020 & 2027F |
4 Indonesia Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Indonesia Biobanking Market Trends |
6 Indonesia Biobanking Market, By Types |
6.1 Indonesia Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Biobanking Market Revenues & Volume, By Type, 2018 - 2027F |
6.1.3 Indonesia Biobanking Market Revenues & Volume, By Equipment, 2018 - 2027F |
6.1.4 Indonesia Biobanking Market Revenues & Volume, By Consumables, 2018 - 2027F |
6.1.5 Indonesia Biobanking Market Revenues & Volume, By Services, 2018 - 2027F |
6.1.6 Indonesia Biobanking Market Revenues & Volume, By Software, 2018 - 2027F |
6.2 Indonesia Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Biobanking Market Revenues & Volume, By Regenerative Medicine, 2018 - 2027F |
6.2.3 Indonesia Biobanking Market Revenues & Volume, By Life Science Research, 2018 - 2027F |
6.2.4 Indonesia Biobanking Market Revenues & Volume, By Clinical Research, 2018 - 2027F |
6.3 Indonesia Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 Indonesia Biobanking Market Revenues & Volume, By Blood Products, 2018 - 2027F |
6.3.3 Indonesia Biobanking Market Revenues & Volume, By Human Tissues, 2018 - 2027F |
6.3.4 Indonesia Biobanking Market Revenues & Volume, By Nucleic Acids, 2018 - 2027F |
6.3.5 Indonesia Biobanking Market Revenues & Volume, By Cell Lines, 2018 - 2027F |
6.3.6 Indonesia Biobanking Market Revenues & Volume, By Biological Fluids, 2018 - 2027F |
6.3.7 Indonesia Biobanking Market Revenues & Volume, By Human Waste Products, 2018 - 2027F |
7 Indonesia Biobanking Market Import-Export Trade Statistics |
7.1 Indonesia Biobanking Market Export to Major Countries |
7.2 Indonesia Biobanking Market Imports from Major Countries |
8 Indonesia Biobanking Market Key Performance Indicators |
9 Indonesia Biobanking Market - Opportunity Assessment |
9.1 Indonesia Biobanking Market Opportunity Assessment, By Type, 2020 & 2027F |
9.2 Indonesia Biobanking Market Opportunity Assessment, By Applications, 2020 & 2027F |
9.3 Indonesia Biobanking Market Opportunity Assessment, By Sample Type, 2020 & 2027F |
10 Indonesia Biobanking Market - Competitive Landscape |
10.1 Indonesia Biobanking Market Revenue Share, By Companies, 2020 |
10.2 Indonesia Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |